A total of 232 Mexican Americans who met DSM-IV criteria for major depressive disorder were randomly assigned to receive 8 weeks of double-blind treatment with desipramine ( 50-200 mg/day ) or fluoxetine ( 10-40 mg/day ) after a 1-week placebo lead-in period .